Search Results

There are 9168 results for: content related to: Endocrine and testicular changes induced by olanzapine in adult Wistar rats

  1. Olanzapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling and Stefan Leucht

    Published Online : 17 MAR 2010, DOI: 10.1002/14651858.CD006654.pub2

  2. Olanzapine for schizophrenia

    Intervention Review

    The Cochrane Library

    Lorna Duggan, Mark Fenton, John Rathbone, Roland Dardennes, Ahmed El-Dosoky and Saroja Indran

    Published Online : 20 APR 2005, DOI: 10.1002/14651858.CD001359.pub2

  3. Olanzapine alone or in combination for acute mania

    Intervention Review

    The Cochrane Library

    Jennifer M Rendell, Harm J Gijsman, Paul K Keck, Guy Goodwin and John Geddes

    Published Online : 20 JAN 2003, DOI: 10.1002/14651858.CD004040

  4. Olanzapine in long-term treatment for bipolar disorder

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Jennifer M Rendell and John Geddes

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD004367.pub2

  5. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses

    Intervention Review

    The Cochrane Library

    Ravindra B Belgamwar and Mark Fenton

    Published Online : 20 APR 2005, DOI: 10.1002/14651858.CD003729.pub2

  6. Clozapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Claudia Asenjo Lobos, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz and Stefan Leucht

    Published Online : 10 NOV 2010, DOI: 10.1002/14651858.CD006633.pub2

  7. You have free access to this content
    Olanzapine pamoate: a stick in time?

    International Journal of Clinical Practice

    Volume 63, Issue 1, January 2009, Pages: 140–150, L. Citrome

    Version of Record online : 1 OCT 2008, DOI: 10.1111/j.1742-1241.2008.01900.x

  8. Pharmacological interventions for borderline personality disorder

    Intervention Review

    The Cochrane Library

    Jutta Stoffers, Birgit A Völlm, Gerta Rücker, Antje Timmer, Nick Huband and Klaus Lieb

    Published Online : 16 JUN 2010, DOI: 10.1002/14651858.CD005653.pub2

  9. You have free access to this content
    Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 6, June 2014, Pages: 747–759, Thomas Vella and Janet Mifsud

    Version of Record online : 7 JAN 2014, DOI: 10.1111/jphp.12209

  10. Risperidone versus olanzapine for schizophrenia

    Intervention Review

    The Cochrane Library

    Mahesh B Jayaram, Prakash Hosalli and T S Stroup

    Published Online : 19 APR 2006, DOI: 10.1002/14651858.CD005237.pub2

  11. You have free access to this content
    Hormonal and Metabolic Effects of Olanzapine and Clozapine Related to Body Weight in Rodents

    Obesity

    Volume 14, Issue 1, January 2006, Pages: 36–51, Vance L. Albaugh, Cathy R. Henry, Nicholas T. Bello, Andras Hajnal, Susan L. Lynch, Beth Halle and Christopher J. Lynch

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2006.6

  12. You have full text access to this OnlineOpen article
    Antipsychotics inhibit glucose transport: Determination of olanzapine binding site inStaphylococcus epidermidis glucose/H+ symporter

    FEBS Open Bio

    Volume 5, Issue 1, January 01, 2015, Pages: 335–340, Petr Babkin, Alayna M. George Thompson, Cristina V. Iancu, D. Eric Walters and Jun-yong Choe

    Version of Record online : 15 APR 2015, DOI: 10.1016/j.fob.2015.04.006

  13. Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3

    Human Psychopharmacology: Clinical and Experimental

    Volume 31, Issue 2, March 2016, Pages: 83–92, Maho Okubo, Momoko Narita, Norie Murayama, Youichi Akimoto, Akiko Goto and Hiroshi Yamazaki

    Version of Record online : 8 FEB 2016, DOI: 10.1002/hup.2515

  14. Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1128–1135, M. Ikegami, H. Ikeda, T. Ohashi, M. Ohsawa, Y. Ishikawa, M. Kai, A. Kamei and J. Kamei

    Version of Record online : 11 JUL 2013, DOI: 10.1111/dom.12148

  15. You have free access to this content
    The Role of Thermogenesis in Antipsychotic Drug-induced Weight Gain

    Obesity

    Volume 17, Issue 1, January 2009, Pages: 16–24, Aneta Stefanidis, Aaron N.A. Verty, Andrew M. Allen, Neil C. Owens, Michael A. Cowley and Brian J. Oldfield

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.468

  16. You have free access to this content
    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany G El-Sayeh, Stefan Leucht and Jun Xia

    Published Online : 2 JAN 2014, DOI: 10.1002/14651858.CD006569.pub5

  17. Olanzapine Transfer By Human Placenta

    Clinical and Experimental Pharmacology and Physiology

    Volume 26, Issue 9, September 1999, Pages: 691–697, S Schenker, Y Yang, E Mattiuz, D Tatum and M Lee

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1440-1681.1999.03111.x

  18. You have free access to this content
    The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine

    British Journal of Clinical Pharmacology

    Volume 71, Issue 4, April 2011, Pages: 611–615, Tore Haslemo, Helge Refsum and Espen Molden

    Version of Record online : 11 MAR 2011, DOI: 10.1111/j.1365-2125.2010.03880.x

  19. UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 2, August 2012, Pages: 221–227, T Haslemo, I Loryan, N Ueda, B Mannheimer, L Bertilsson, M Ingelman-Sundberg, E Molden and E Eliasson

    Version of Record online : 20 JUN 2012, DOI: 10.1038/clpt.2012.46

  20. Second-generation antipsychotics for major depressive disorder and dysthymia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Anna M Depping, Andrea Gaudchau, Werner Kissling and Stefan Leucht

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD008121.pub2